Laboratorio Reig Jofre, S.A. is a fully integrated pharmaceutical company founded in 1929 and headquartered in Barcelona, Spain, specializing in the research, development, manufacturing, and marketing... Laboratorio Reig Jofre, S.A. is a fully integrated pharmaceutical company founded in 1929 and headquartered in Barcelona, Spain, specializing in the research, development, manufacturing, and marketing of innovative pharmaceutical products worldwide. It operates across three core areas: pharmaceutical technologies focusing on sterile injectables, lyophilized products, and penicillin-derived antibiotics; specialty pharmacare targeting dermatology, osteoarticular disorders, women's health, and respiratory conditions; and consumer healthcare featuring nutritional supplements and OTC products under the Forté Pharma brand, primarily in France, Belgium, Spain, and Portugal. With over 1,300 employees and four production centers in Europe—including sites in Toledo, Barcelona, and Malmö—the company provides CDMO and CMO services, leveraging expertise in aseptic fill-finish, analytical development, and regulatory approvals from EMA, GMP, PMDA, and others. Listed on the Spanish stock exchange, Laboratorio Reig Jofre, S.A. maintains a global footprint through subsidiaries in nine countries and partnerships in over 70 nations, closing 2023 with €316 million in sales and positioning itself as the fifth-largest listed Spanish pharmaceutical firm by revenue. Its commitment to R&D and adaptability underscores its role in bridging research and essential health solutions.
Greenhouse Gas (GHG) Emissions data not yet covered for Laboratorio Reig Jofre
We have not yet reviewed Laboratorio Reig Jofre's disclosures for Greenhouse Gas (GHG) Emissions data.
If this data is relevant to your work, you can submit a data coverage request and our team
will investigate the company's disclosures and capture the data if available.